What is the price-to-earnings ratio of DarioHealth?
The price-earnings ratio of DarioHealth is currently -1.21.
DarioHealth P/E 2024
DarioHealth P/E
-1.21
Ticker
DRIO
ISIN
US23725P2092
WKN
A2PU1R
As of Dec 3, 2024, DarioHealth's P/E ratio was -1.21, a -32.4% change from the -1.79 P/E ratio recorded in the previous year.
The DarioHealth P/E history
DarioHealth Aktienanalyse
What does DarioHealth do?
DarioHealth Corp specializes in digital health solutions. It was founded in 2011 and is based in New York, USA. It was founded by Dror Bacher and Oren Fuerst with the goal of helping people with diabetes live healthier lives. They developed a mobile app that allows people with diabetes to monitor their blood sugar levels and improve their health. The company's business model focuses on developing and selling digital health solutions for people with diabetes and other chronic conditions. They work with insurance companies and healthcare providers to sell their products and services to patients. The company is divided into different divisions that cater to the needs of diabetes patients and people with chronic conditions. These divisions include the DarioHealth app, DarioEngage, DarioHealth for Employers, and DarioHealth for Pharma. The company offers a range of products including the DarioHealth Smart Meter, DarioHealth Smart Insulin Pen, and DarioHealth Smart CGM. Overall, DarioHealth Corp is an innovative company that offers tailored digital health solutions for people with diabetes and other chronic conditions. DarioHealth ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering DarioHealth's P/E Ratio
The Price to Earnings (P/E) Ratio of DarioHealth is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing DarioHealth's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of DarioHealth is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in DarioHealth’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about DarioHealth stock
How has the price-earnings ratio of DarioHealth changed compared to last year?
The price-to-earnings ratio of DarioHealth has increased by -32.4% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of DarioHealth high compared to other companies?
Yes, the price-to-earnings ratio of DarioHealth is high compared to other companies.
How does an increase in the price-earnings ratio of DarioHealth affect the company?
An increase in the price-earnings ratio of DarioHealth would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of DarioHealth affect the company?
A decrease in the price-earnings ratio of DarioHealth would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of DarioHealth?
Some factors that influence the price-earnings ratio of DarioHealth are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does DarioHealth pay?
Over the past 12 months, DarioHealth paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, DarioHealth is expected to pay a dividend of 0 USD.
What is the dividend yield of DarioHealth?
The current dividend yield of DarioHealth is .
When does DarioHealth pay dividends?
DarioHealth pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of DarioHealth?
DarioHealth paid dividends every year for the past 0 years.
What is the dividend of DarioHealth?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is DarioHealth located?
DarioHealth is assigned to the 'Health' sector.
Wann musste ich die Aktien von DarioHealth kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of DarioHealth from 12/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.
When did DarioHealth pay the last dividend?
The last dividend was paid out on 12/3/2024.
What was the dividend of DarioHealth in the year 2023?
In the year 2023, DarioHealth distributed 0 USD as dividends.
In which currency does DarioHealth pay out the dividend?
The dividends of DarioHealth are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von DarioHealth
Our stock analysis for DarioHealth Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DarioHealth Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
